n.无纤维蛋白原血症；纤维蛋白原缺乏血症

She was diagnosed with afibrinogenemia, which led to severe bleeding complications.
她被诊断为无纤维蛋白原血症，导致了严重的出血并发症。
Afibrinogenemia is a rare genetic disorder that affects the production of blood clots.
无纤维蛋白原血症是一种罕见的遗传性疾病，影响血液凝块的形成。
Emergency treatment for afibrinogenemia involves administering clotting factors intravenously.
对于无纤维蛋白原血症的紧急治疗包括静脉注射凝血因子。
The patient's prolonged bleeding was attributed to their underlying afibrinogenemia condition.
病人的持续出血归因于他们无纤维蛋白原血症的根本原因。
Genetic counseling is essential for families with a history of afibrinogenemia to prevent recurrence.
对有无纤维蛋白原血症家族史的家庭进行遗传咨询以防止复发至关重要。
Hereditary afibrinogenemia can be detected through newborn screening programs in many countries.
在许多国家，可以通过新生儿筛查项目检测到遗传性无纤维蛋白原血症。
Proper management of afibrinogenemia includes regular monitoring and medical intervention as needed.
对无纤维蛋白原血症的恰当管理包括定期监测并根据需要进行医疗干预。
Severe trauma can exacerbate afibrinogenemia symptoms in individuals with this condition.
对于患有此病的人，严重创伤可能会加重无纤维蛋白原血症的症状。
Affected individuals may require lifelong anticoagulant therapy to manage the risks associated with afibrinogenemia.
患者可能需要终身抗凝血疗法来管理与无纤维蛋白原血症相关的风险。
Research continues to explore potential gene therapies for treating afibrinogenemia in the future.
对无纤维蛋白原血症的未来治疗，基因疗法的研究仍在继续。